Nine Monthly Results Results Snapshot
Figures in Cr
Standalone Nine Monthly Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Nine Monthly Analysis Highlights
Net Sales
YoY Growth in nine months ended Dec 2025 is 18.01% vs 24.62% in Dec 2024
Standalone Net Profit
YoY Growth in nine months ended Dec 2025 is 39.32% vs 15.16% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in nine months ended Dec 2025 is 28.39% vs 30.44% in Dec 2024
Interest
YoY Growth in nine months ended Dec 2025 is -5.97% vs 105.25% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in nine months ended Dec 2025 has improved from Dec 2024
Compare Nine Monthly Results Of Dr Agarwal's Eye With
Figures in Cr
Standalone Nine Monthly Results
Change(INR)
Change(%)
Net Sales
350.86
1,117.70
-766.84
-68.61%
Other Operating Income
0.00
0.00
0.00
Total Operating income
350.86
1,117.70
-766.84
-68.61%
Raw Material Cost
0.00
192.04
-192.04
-100.00%
Purchase of Finished goods
35.70
0.00
35.70
(Increase) / Decrease In Stocks
0.19
0.00
0.19
Employee Cost
67.72
213.42
-145.70
-68.27%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
86.00
292.80
-206.80
-70.63%
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
49.67
213.03
-163.36
-76.68%
Total Expenditure (Excl Depreciation)
239.28
911.29
-672.01
-73.74%
Operating Profit (PBDIT) excl Other Income
111.58
206.41
-94.83
-45.94%
Other Income
4.25
21.42
-17.17
-80.16%
Operating Profit (PBDIT)
115.83
227.83
-112.00
-49.16%
Interest
9.92
4.53
5.39
118.98%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
105.91
223.30
-117.39
-52.57%
Depreciation
33.55
32.29
1.26
3.90%
Profit Before Tax
72.36
191.01
-118.65
-62.12%
Tax
18.50
49.09
-30.59
-62.31%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
53.86
141.92
-88.06
-62.05%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
53.86
141.92
-88.06
-62.05%
Equity Capital
4.83
91.67
-86.84
-94.73%
Face Value
10.00
10.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
0.00
0.00
0.00
Operating Profit Margin (Excl OI)
31.80%
18.47%
0.00
13.33%
Gross Profit Margin
30.19%
19.98%
0.00
10.21%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Nine Monthly - Net Sales
Net Sales 350.86 Cr
in Dec 2025Figures in Cr
YoY Growth in nine months ended Dec 2025 is 18.01% vs 24.62% in Dec 2024
Nine Monthly - Standalone Net Profit
Standalone Net Profit 53.86 Cr
in Dec 2025Figures in Cr
YoY Growth in nine months ended Dec 2025 is 39.32% vs 15.16% in Dec 2024
Nine Monthly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 111.58 Cr
in Dec 2025Figures in Cr
YoY Growth in nine months ended Dec 2025 is 28.39% vs 30.44% in Dec 2024
Nine Monthly - Interest
Interest 9.92 Cr
in Dec 2025Figures in Cr
YoY Growth in nine months ended Dec 2025 is -5.97% vs 105.25% in Dec 2024
Nine Monthly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 31.80%
in Dec 2025Figures in %
YoY Growth in nine months ended Dec 2025 has improved from Dec 2024
